Results 131 to 140 of about 4,608 (197)

Why, When, and How to Treat Dynamic Forehead Lines with Botulinum Toxin Type A. [PDF]

Toxins (Basel)
de Sanctis Pecora C, Kerscher M, Muniz M, Trindade de Almeida A.   +3 more
europepmc   +1 more source

Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. [PDF]

Toxins (Basel)
Srinoulprasert Y, Sirisuthivoranunt S, Sripatumtong C, Tansit T, Yamlexnoi P, Meethong O, Wanitphakdeedecha R.   +6 more
europepmc   +1 more source

RTP004 Peptide Binds to Botulinum Neurotoxin, Increases Cell Surface Binding, and Enhances Cellular SNAP-25 Cleavage. [PDF]

Toxins (Basel)
Batista AF, Singh R, Lee F, Zhuo S, Leonoudakis D, Gallagher CJ.   +5 more
europepmc   +1 more source

Ultrasound-guided botulinum neurotoxin type A injection: A novel technique for gummy smile correction

Asian Journal of Surgery
Kuangyun Tang, Yange Wu, Sheng Wang, Xuepeng Chen   +3 more
openaire   +1 more source

Camels' antibody response to <i>botulinum</i> toxin-A (Botox). [PDF]

Open Vet J
Falemban B, Marzok M, Dhafiri MA, Saleh SM, Al-Wail AA, Almubarak AI, Fayez M, Salem M, Hussen J.   +8 more
europepmc   +1 more source

Rare Localized Adverse Reaction to Botulinum Toxin Type A in a Patient Without Allergic History: A Case Report. [PDF]

Aesthet Surg J Open Forum
Muner RR, Moreira AA, Espasandin I, Tedesco AD, Ferreira ACM, Barbosa AP.   +5 more
europepmc   +1 more source

Highly Cited Research on Botulinum Toxin: A Bibliometric Analysis of Clinical Trends, Influential Evidence, and Healthcare-Relevant Applications (1991-2022). [PDF]

Healthcare (Basel)
Ho YS, de Sousa Mendes LA, De la Torre Canales G, Christidis N.   +3 more
europepmc   +1 more source

Clinical Presentation and Evolution of Isolated Focal and Segmental Dystonia in Adults - 20 Years' Experience from a Botulinum Toxin Clinic. [PDF]

Ann Indian Acad Neurol
Vijayaraghavan A, Krishnan S, Patel KS, Mohan SK, Radhakrishnan V, Sanalkumar A, Sarma SG, Cherian A, Puthanveedu DK.   +8 more
europepmc   +1 more source

Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A. [PDF]

Toxins (Basel)
Al-Sabi A, Lawrence GW.
europepmc   +1 more source

The Neuromuscular Junction Distribution in the Upper Face: An Anatomy-to-Practice Review to Inform Botulinum Toxin Type A Treatment Planning. [PDF]

J Cosmet Dermatol
Magacho-Vieira FN.
europepmc   +1 more source